Announcements Trials
Browse Landscape

Phase

Phase 1 31Phase 2 28Phase 1/2 16Phase 3 3Phase NA 2Phase 2/3 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 13Lymphoid 2Thoracic 1Plasma cell 1Myeloid 1Breast 1

Conditions

Recurrence 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 47Rituximab 34Exercise 25fludarabine phosphate 24Methotrexate 24Blood Specimen Collection 23Vincristine 21Cytarabine 21Radiotherapy 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Prednisone 16Melphalan 16Etoposide 16Cyclosporine 16Methods 15Dexamethasone 15Busulfan 15Antilymphocyte Serum 15fludarabine 14Doxorubicin 14Educational Status 13Mycophenolic Acid 12Magnetic Resonance Spectroscopy 11Early Intervention, Educational 11Therapeutics 10Surveys and Questionnaires 9Standard of Care 9Prednisolone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Azacitidine × Lymphoid × Clear all
NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

The First Affiliated Hospital of Soochow University

Phase NA Unknown
20 enrolled
Lymphoid

Recurrence, Lymphoma, B-Cell

NCT05772728 2023-03-16

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
23 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡